Literature DB >> 26152838

Oral pseudoephedrine decreases the rate of transmucosal nitrous oxide exchange for the middle ear.

Miriam S Teixeira1,2, Cuneyt M Alper1,2, Brian S Martin3,4, Brendan M Cullen Doyle5, William J Doyle1,2.   

Abstract

OBJECTIVES/HYPOTHESIS: Determine if oral treatment with a vasoconstrictor decreases the blood to middle ear exchange rate of the perfusion-limited gas, nitrous oxide (N2O). STUDY
DESIGN: Randomized, double-blind, crossover study.
METHODS: Ten adult subjects with and 10 without past middle ear disease completed paired experimental sessions, identical except for oral treatment with either pseudoephedrine hydrochloride or lactose placebo. At each session, subjects were fitted with a nonrebreathing mask and breathed room air for 20 minutes (acclimation period), 50% N2O:50% O2 for 20 minutes (experimental period), and 100% O2 for 10 minutes (recovery period). Throughout, heart rate, blood pressure, and O2 saturation were monitored, and bilateral middle ear pressures were recorded by tympanometry every minute. The primary outcome was the slope of the middle ear pressure-time function for the experimental period, which estimates the volume N2O exchange rate. Using repeated measures analysis of variance, the effects of group (disease history), treatment (active vs. placebo), and period (1 vs. 2) on the recorded vital signs, and of group, treatment, and ear (left/right) on the middle ear pressure-time slope were evaluated for statistical significance.
RESULTS: Statistically significant effects of period on O2 saturation (period 2 > period 1) and of treatment on heart rate (active > placebo) were documented. Only treatment was statistically significant for the middle ear pressure-time slope, with a shallower slope characterizing the active treatment session.
CONCLUSIONS: The volume exchange rate across the middle ear mucosa of perfusion-limited gases can be modulated pharmacologically. Theoretically, similar drugs can be used to reduce the requisite eustachian tube opening efficiency for adequate middle ear pressure regulation. LEVEL OF EVIDENCE: 1b.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Adults; N2O breathing; decongestants; middle ear; modeling; pressure regulation

Mesh:

Substances:

Year:  2015        PMID: 26152838      PMCID: PMC4546852          DOI: 10.1002/lary.25221

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  34 in total

Review 1.  The pharmacology of alpha-adrenergic decongestants.

Authors:  D A Johnson; J G Hricik
Journal:  Pharmacotherapy       Date:  1993 Nov-Dec       Impact factor: 4.705

2.  Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children.

Authors:  F E Simons; X Gu; W T Watson; K J Simons
Journal:  J Pediatr       Date:  1996-11       Impact factor: 4.406

3.  Diffusion of oxygen from gas pockets to capillaries.

Authors:  H D Van Liew; W H Schoenfisch; M M Goldberg
Journal:  Microvasc Res       Date:  1969-04       Impact factor: 3.514

4.  Human middle ear gas composition studied by mass spectrometry.

Authors:  L Hergils; B Magnuson
Journal:  Acta Otolaryngol       Date:  1990 Jul-Aug       Impact factor: 1.494

5.  In vivo observation with magnetic resonance imaging of middle ear effusion in response to experimental underpressures.

Authors:  J D Swarts; C M Alper; J T Seroky; K H Chan; W J Doyle
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-07       Impact factor: 1.547

6.  Simulation of exchanges of multiple gases in bubbles in the body.

Authors:  M E Burkard; H D Van Liew
Journal:  Respir Physiol       Date:  1994-02

Review 7.  Pharmacokinetics of oral decongestants.

Authors:  I Kanfer; R Dowse; V Vuma
Journal:  Pharmacotherapy       Date:  1993 Nov-Dec       Impact factor: 4.705

8.  Eustachian tube function in the rhesus monkey model of cleft palate.

Authors:  M L Casselbrant; W J Doyle; E I Cantekin; A S Ingraham
Journal:  Cleft Palate J       Date:  1985-07

9.  Effects of intranasal challenge with histamine, bradykinin and prostaglandin on middle ear pressure and blood flow in cynomolgus monkeys.

Authors:  J T Seroky; C M Alper; R Tabari; W J Doyle
Journal:  Acta Otolaryngol       Date:  1995-01       Impact factor: 1.494

10.  Middle ear gas exchange in rhesus monkeys.

Authors:  W J Doyle; J T Seroky
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-08       Impact factor: 1.547

View more
  3 in total

1.  A formal description of middle ear pressure-regulation.

Authors:  William J Doyle
Journal:  Hear Res       Date:  2017-08-24       Impact factor: 3.208

2.  Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.

Authors:  Miriam S Teixeira; Cuneyt M Alper; Brian S Martin; Selma Cetin; Jenna A El-Wagaa; William J Doyle
Journal:  Ann Otol Rhinol Laryngol       Date:  2017-01-19       Impact factor: 1.547

3.  Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.

Authors:  Miriam S Teixeira; Cuneyt M Alper; Brian S Martin; Narmin Helal; Brendan M Cullen Doyle; William J Doyle
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-11-26       Impact factor: 1.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.